EA201590697A1 - Производные кетамина - Google Patents

Производные кетамина

Info

Publication number
EA201590697A1
EA201590697A1 EA201590697A EA201590697A EA201590697A1 EA 201590697 A1 EA201590697 A1 EA 201590697A1 EA 201590697 A EA201590697 A EA 201590697A EA 201590697 A EA201590697 A EA 201590697A EA 201590697 A1 EA201590697 A1 EA 201590697A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
ketamine
methods
formula
relates
Prior art date
Application number
EA201590697A
Other languages
English (en)
Inventor
Джеймс Уоллес Слэй
Вильям Александер Денни
Джини Джоуз
Сварналатха Акуратия Гамадж
Мартин Грегори Харви
Логан Джеймс Восс
Original Assignee
Окленд Юнисервисиз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Окленд Юнисервисиз Лимитед filed Critical Окленд Юнисервисиз Лимитед
Publication of EA201590697A1 publication Critical patent/EA201590697A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton

Abstract

Изобретение относится к производным кетамина формулы (I), фармацевтическим композициям, содержащим указанные производные, и способам лечения боли, включающим их введение, а также к их применению для получения лекарственных средств для лечения боли. Изобретение также относится к способам анестезии и способам седации субъекта, включающим введение производных кетамина формулы (II).
EA201590697A 2012-10-08 2013-10-08 Производные кетамина EA201590697A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ60288512 2012-10-08
NZ61120213 2013-05-28
PCT/IB2013/059191 WO2014057414A1 (en) 2012-10-08 2013-10-08 Ketamine derivatives

Publications (1)

Publication Number Publication Date
EA201590697A1 true EA201590697A1 (ru) 2015-09-30

Family

ID=50476991

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590697A EA201590697A1 (ru) 2012-10-08 2013-10-08 Производные кетамина

Country Status (13)

Country Link
US (3) US20150259277A1 (ru)
EP (1) EP2903963A4 (ru)
JP (2) JP6309957B2 (ru)
KR (1) KR20150065873A (ru)
CN (1) CN104837810B (ru)
AU (1) AU2013328280B2 (ru)
BR (1) BR112015007647A2 (ru)
CA (1) CA2922340A1 (ru)
EA (1) EA201590697A1 (ru)
HK (1) HK1212673A1 (ru)
IN (1) IN2015DN03854A (ru)
MX (1) MX2015004362A (ru)
WO (1) WO2014057414A1 (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2756512C1 (ru) * 2018-01-10 2021-10-01 ЭксДабл-ЮФАРМА ЛТД. Пролекарства кетамина, его композиции и применения
US11690811B2 (en) 2021-08-13 2023-07-04 XWPharma Ltd. Pharmaceutical compositions and oral dosage forms of ketamine derivatives

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150065873A (ko) * 2012-10-08 2015-06-15 오클랜드 유니서비시즈 리미티드 케타민 유도체
US20160332962A1 (en) * 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
AU2016288188B2 (en) 2015-06-27 2021-08-05 Shenox Pharmaceuticals, Llc Ketamine transdermal delivery system
US11827606B2 (en) 2015-11-18 2023-11-28 Spirify Pharma Inc. Phenyl cyclohexanone derivatives and methods of making and using them
WO2017087388A1 (en) * 2015-11-18 2017-05-26 Mitchell Woods Pharmaceuticals, Inc. Phenyl cyclohexanone derivatives and methods of making and using them
US10919842B2 (en) * 2016-03-25 2021-02-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
WO2019186357A1 (en) * 2018-03-26 2019-10-03 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
EP3802480B1 (en) * 2018-06-04 2023-08-02 The United States of America, as represented by the Secretary, Department of Health and Human Services Process for synthesis and purification of (2r,6r)-hydroxynorketamine
CN112125816A (zh) * 2020-03-17 2020-12-25 国药集团工业有限公司 一种***、其衍生物或其盐的消旋化方法
CN115677444A (zh) * 2022-10-26 2023-02-03 公安部第三研究所 同位素毒品代谢物标记化合物及其制备方法、用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254124A (en) 1962-06-29 1966-05-31 Parke Davis & Co Aminoketones and methods for their production
GB1134146A (en) * 1967-09-15 1968-11-20 Parke Davis & Co New organic amines and methods for their production
US5019583A (en) 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5466700A (en) 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5866591A (en) 1996-09-11 1999-02-02 Glaxo Wellcome Inc. Stable formulations of remifentanil
EP1272463A1 (en) * 2000-01-28 2003-01-08 Rohm And Haas Company Enhanced propertied pharmaceuticals
US20040248963A1 (en) 2001-11-23 2004-12-09 Bueno Melendo Ana Belen Prodrugs of excitatory amino acids
ATE492565T1 (de) 2002-01-31 2011-01-15 Randox Lab Ltd Immunogene, antikörper und konjugate für ketamin und dessen metaboliten
AU2003291037A1 (en) * 2002-11-18 2004-06-15 Yaupon Therapeutics, Inc. Analgesic uses of norketamine and ketamine/norketamine prodrugs
EA017264B1 (ru) 2005-09-28 2012-11-30 Аурис Медикаль Аг Применение композиции арилциклоалкиламида для получения лекарственного препарата для лечения нарушения внутреннего уха
WO2008134525A1 (en) 2007-04-26 2008-11-06 Auspex Pharmaeuticals, Inc. Deuterium labelled ketamine
EP2766339B1 (en) 2011-10-14 2021-06-09 The United States Of America, as represented by the Secretary, Department of Health & Human Services The use of (2r, 6r)-hydroxynorketamine and other stereoisomeric hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
KR20150065873A (ko) * 2012-10-08 2015-06-15 오클랜드 유니서비시즈 리미티드 케타민 유도체

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2756512C1 (ru) * 2018-01-10 2021-10-01 ЭксДабл-ЮФАРМА ЛТД. Пролекарства кетамина, его композиции и применения
US11440874B2 (en) 2018-01-10 2022-09-13 XWPharma Ltd. Ketamine derivatives and compositions thereof
US11690811B2 (en) 2021-08-13 2023-07-04 XWPharma Ltd. Pharmaceutical compositions and oral dosage forms of ketamine derivatives

Also Published As

Publication number Publication date
CN104837810A (zh) 2015-08-12
MX2015004362A (es) 2015-12-08
US10239825B2 (en) 2019-03-26
JP2018127466A (ja) 2018-08-16
US20190169113A1 (en) 2019-06-06
EP2903963A1 (en) 2015-08-12
JP2015535847A (ja) 2015-12-17
WO2014057414A1 (en) 2014-04-17
IN2015DN03854A (ru) 2015-10-02
KR20150065873A (ko) 2015-06-15
HK1212673A1 (zh) 2016-06-17
US20150259277A1 (en) 2015-09-17
CA2922340A1 (en) 2014-04-17
AU2013328280A1 (en) 2015-05-14
JP6309957B2 (ja) 2018-04-11
CN104837810B (zh) 2019-08-06
EP2903963A4 (en) 2016-05-25
AU2013328280B2 (en) 2017-12-21
US20170190653A1 (en) 2017-07-06
BR112015007647A2 (pt) 2017-07-04
WO2014057414A9 (en) 2014-12-18

Similar Documents

Publication Publication Date Title
EA201590697A1 (ru) Производные кетамина
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
EA201591166A1 (ru) Ингибиторы аутотаксина
EA201391029A1 (ru) Производные оксазина и их применение при лечении неврологических нарушений
EA201490647A1 (ru) Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции
EA202090486A3 (ru) Соединения для лечения спинальной мышечной атрофии
EA201490888A1 (ru) Новые производные пурина и их применение для лечения заболевания
EA201590450A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
EA201391106A1 (ru) Новые гетероциклические производные
EA201200176A1 (ru) Производные оксазина и их применение для лечения неврологических нарушений
UA109991C2 (xx) Карбаматні сполуки, їх отримання і застосування
EA201591371A1 (ru) Пиридиновые производные в качестве легкоразлагаемых ингибиторов rock
MD4496C1 (ru) Аналоги 2'-замещенных карба-нуклеозидов для противовирусного лечения
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
EA201491672A1 (ru) Гетероциклильные соединения как ингибиторы mek
EA201590371A1 (ru) 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний
EA201591195A1 (ru) Новые хинолоновые производные
EA201492050A1 (ru) Модуляторы ядерного транспорта и их применение
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EA201390984A1 (ru) Гетероциклические соединения, подходящие для лечения дислипидемии
MX342924B (es) Nuevos compuestos disustituidos de 3,4-diamino-3-ciclobuteno-1,2-d iona para uso en el tratamiento de patologias mediadas por quimiocinas.
EA201600434A1 (ru) Применение производных бензимидазолпролина
EA201490630A1 (ru) 6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы
EA201690183A1 (ru) Замещенные пиразолопиридинамины
EA201490516A1 (ru) Бифенилкарбоксиамиды в качестве ингибиторов rock-киназ